Skip to main content
. 2022 Sep 8;12(9):2173. doi: 10.3390/diagnostics12092173

Table 2.

Baseline characteristics of the study population according to runoff characteristics.

Variable Runoff Characteristics p Value
Normal (n = 100) Slow (n = 24)
Age (years) 50.53 ± 12.35 47.70 ± 13.28 =0.3
Male-# pts (%) 67 (67%) 15 (62.5%) =0.7
BMI 27.70 ± 5.20 27.79 ± 6.87 =0.7
Hypertension-# pts (%) 71 (71%) 17 (70.8%) =1.0
Diabetes mellitus-# pts (%) 15 (15%) 2 (8.3%) =0.4
Glycemia (mg/dL) 104.89 ± 27.33 110.48 ± 48.55 =0.4
Total cholesterol (mg/dL) 167.26 ± 43.49 182.96 ± 40.27 =0.1
HDL (mg/dL) 50.24 ± 16.86 46.65 ± 9.31 =0.3
LDL (mg/dL) 94.56 ± 35.35 113.28 ± 43.24 =0.03
Triglycerides (mg/dL) 115.53 ± 62.81 133.57 ± 86.55 =0.2
Smoking-# pts (%) 15 (15%) 6 (25%) =0.2
Angina-# pts (%) 32 (32%) 12 (50%) =0.4
NYHA II-# pts (%) 21 (65.6%) 6 (85.7%) -
NYHA III-# pts (%) 10 (31.3%) 1 (14.3%) -
NYHA IV-# pts (%) 1 (3.1%) 0 (0%) =0.1
DCM-# pts (%) 24 (24%) 4 (16.7%) =0.4
ASCVD risk score (%) 12.16 ± 9.52 10.28 ± 11.98 =0.6
LVEF (%) 55 ± 13 59 ± 13 =0.2
Statins-# pts (%) 70 (70%) 14 (58%) =0.3
Betablockers-# pts (%) 21(30%) 4 (23%) =0.6
Antithrombotics-# pts (%) 51 (52%) 11 (45%) =0.5
ACEi-# pts (%) 75 (75%) 17 (71%) =0.7
Diuretics-# pts (%) 14 (14%) 1 (4%) =0.2

HDL = high-density lipoprotein; LDL = low-density lipoprotein; BMI= Body Mass Index; NYHA = New York Heart Association; DCM = dilated cardiomyopathy; ASCVD = atherosclerotic cardiovascular disease; LVEF = left ventricular ejection fraction; ACEi = Angiotensin converting enzyme inhibitor; pts= patients; in bold the p value that was significant.